INSR and Cognitive impairment: Defining the relationship between ERS and insulin receptor signaling in the brains of obese rats during cognitive decline will help determine the mechanism of metabolic and cognitive impairment, and may facilitate the development of novel therapeutic agents in diabetes-associated cognitive decline (DACD).